Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05325931 · ClinicalTrials.gov registry record · NA
1-Week Dispensing Evaluation of Kalifilcon A Daily Disposable Multifocal Compared to Ultra for Presbyopia
A NA study, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT05325931 is a NA study that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 30 participants.
The verdict
NCT05325931, a NA study, has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
Experienced soft contact lens wearing subjects will be enrolled in this 1-week, confirmatory, randomized, bilateral, 2-way crossover, double masked (subject and investigator), repeated measures, dispensing study. All subjects will be seen for a Screening/Dispensing Visit at which informed consent will be obtained and eligibility will be assessed. If subjects satisfy all eligibility criteria and none of the exclusion criteria, subjects will be fit and dispensed study lenses according to unique randomization schedules that will be provided to each Investigator If vision is unsatisfactory in the original dispensed lenses, additional lens powers may be trialed.
Interventions
- DEVICE kalifilcon A Daily Disposable Multifocal
- DEVICE samfilcon A for Presbyopia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2022-02-25 |
| Est. Completion | 2022-03-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05325931
The ClinicalTrials.gov registry entry for NCT05325931 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch & Lomb Incorporated, which has 174 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which kalifilcon A Daily Disposable Multifocal is the first listed.
NCT05325931 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05325931 about?
NCT05325931 is a clinical study titled "1-Week Dispensing Evaluation of Kalifilcon A Daily Disposable Multifocal Compared to Ultra for Presbyopia". Experienced soft contact lens wearing subjects will be enrolled in this 1-week, confirmatory, randomized, bilateral, 2-way crossover, double masked (subject and investigator), repeated measures, dispensing study. All subjects will be seen for a Screening/Dispensing Visit at which informed consent wi...
What is the current status of trial NCT05325931?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2022-02-25. Estimated completion is 2022-03-28.
What interventions are being tested in trial NCT05325931?
The interventions under investigation include: kalifilcon A Daily Disposable Multifocal (DEVICE), samfilcon A for Presbyopia (DEVICE).
Who is sponsoring clinical trial NCT05325931?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.